Veterinary Hematology Analyzers Market Report 2025

The veterinary hematology analyzers market size has grown strongly in recent years. It will grow from $0.97 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to increase in pet ownership, advancements in veterinary medicine, prevalence of animal diseases, growing awareness of animal health, expansion of veterinary services.

The veterinary hematology analyzers market size is expected to see strong growth in the next few years. It will grow to $1.4 billion in 2029 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to rising pet healthcare expenditure, growth in animal research, increasing pet insurance coverage, globalization of veterinary practices. Major trends in the forecast period include technological advancements, point-of-care hematology testing, remote monitoring and connectivity, focus on small and exotic animals, multiparameter analysis.

The rising prevalence of zoonotic diseases in animals is expected to drive growth in the veterinary hematology analyzer market. A zoonotic disease is an infectious illness caused by harmful microorganisms such as bacteria, viruses, fungi, and parasites that can be transmitted between animals and humans. Veterinary hematology analyzers provide real-time detection of anomalies in blood parameters, enabling veterinarians to swiftly identify zoonotic infections, initiate appropriate treatment, and implement essential preventative measures to prevent their spread. For example, in February 2023, the Council on Foreign Relations, a US-based think tank, estimated that 60 percent of known infectious diseases and up to 75 percent of new or emerging infectious diseases (EIDs) are of zoonotic origin. Therefore, the increasing prevalence of zoonotic diseases in animals is driving the veterinary hematology analyzers market.

The growth of the veterinary hematology analyzer market is also expected to be fueled by an increase in the pet population. The pet population refers to the total number of domesticated animals kept as pets within a specific geographic area. Veterinary hematology analyzers contribute to monitoring and maintaining the health of the pet population by providing accurate and rapid analysis of blood samples. For instance, as of October 2023, the European Pet Food Industry Federation (FEDIAF) reported an 11% growth in the European pet population in 2022, reaching a total of 340 million pets, predominantly comprising cats (127 million) and dogs (104 million). Therefore, the rise in the pet population is a significant factor driving the growth of the veterinary hematology analyzer market.

The veterinary hematology analyzer market is witnessing a significant trend towards product innovations as major companies strive to enhance their market position. One notable example is Zoetis Inc., a US-based veterinary drug company, which introduced the groundbreaking VETSCAN IMAGYST platform in April 2022. This technology represents a unique offering with AI blood smear, AI fecal, and digital cytology image transfer capabilities in a single, compact device. The VETSCAN IMAGYST platform is designed to complement veterinary hematology analyzers such as the VETSCAN HM5 Hematology Analyzer, providing a comprehensive 5-part CBC differential with 22 parameters in less than 4 minutes.

Major companies in the veterinary hematology analyzers market are increasingly focusing on launching advanced blood analyzers, such as the ST-200 CC Blood Gas Analyzer-Ultra Smart, to gain a competitive advantage. The ST-200 CC Blood Gas Analyzer-Ultra Smart is a medical device that provides advanced and precise testing capabilities for blood gas analysis in critical care environments, improving diagnostic accuracy and efficiency. For example, in September 2024, Zoetis Inc., a US-based pharmaceutical company that produces medicines and vaccinations for pets and livestock, introduced the Vetscan OptiCell. This is the first cartridge-based AI-powered hematology analyzer specifically designed for veterinary use, aimed at significantly enhancing veterinary diagnostics through cutting-edge technology. By offering sophisticated Complete Blood Count (CBC) analysis with lab-quality accuracy at the point of care, this innovative technology aims to advance veterinary diagnostics. The Vetscan OptiCell integrates advanced AI image recognition for more accurate blood cell characterization, reducing costs and space requirements while delivering prompt and reliable results, ultimately enhancing productivity in veterinary clinics.

In June 2023, Mars Incorporated, a prominent US-based supplier of animal care services, acquired Heska Corporation in a strategic move to expand its diagnostics and technology portfolio. The acquisition is aimed at accelerating research and development efforts, fostering innovation, and better serving veterinary professionals and pets. Heska Corp., the acquired entity, is recognized for its pioneering work in developing innovative veterinary hematology analyzers, contributing to advancements in animal healthcare.

Major companies operating in the veterinary hematology analyzers market include Abbott Laboratories, Siemens Healthcare Private Limited, Zoetis Services LLC., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., HORIBA Medical, Sysmex Corp., Chengdu Seamaty Technology Co. Ltd, Getein Biotech Inc., Heska Corporation,Abaxis Inc., Abaxis Inc., HemoCue AB, EKF Diagnostics Holdings PLC, Boule Diagnostics AB, Scil Animal Care Company GmbH, Diatron Mi Apac Private Limited, ERBA Diagnostics Inc., Drew Scientific Inc., Woodley Equipment Company Ltd.,B&E Bio-technology Co. Ltd., Rayto Life and Analytical Sciences Co.Ltd., Genrui Biotech Co. Ltd., Analytical Technologies Limited, Urit Medical Electronics Co. Ltd., Qreserve Inc., Balio Diagnostics, Shezhen Dymind Biotechnology Co. Ltd, Bioevopeak Co. Ltd.

North America was the largest region in the veterinary hematology analyzer market in 2024. The regions covered in the veterinary hematology analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary hematology analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

A veterinary hematology analyzer is a medical device utilized in animal healthcare to generate a complete blood count (CBC) or hemogram, providing a quantitative and qualitative analysis of the blood's constituents, including red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes). These analyzers play a crucial role in veterinary medicine, conducting various analyses such as white blood cell counts, complete blood counts, reticulocyte analyses, and coagulation assays on blood samples.

The primary categories of veterinary hematology analyzers include table-top analyzers and point-of-care analyzers. Table-top analyzers are laboratory instruments designed for testing samples of different compounds and are available for both companion animals and livestock. They employ various analysis parameters such as 2-part WBC differential, 3-part WBC differential, 5-part WBS differential, among others. These analyzers find application in diverse settings, including research institutes, veterinary hospitals and clinics, veterinary diagnostic centers, point-of-care testing, in-house testing, and more.

The veterinary hematology analyzers market research report is one of a series of new reports that provides veterinary hematology analyzers market statistics, including veterinary hematology analyzers industry global market size, regional shares, competitors with a veterinary hematology analyzers market share, detailed veterinary hematology analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary hematology analyzers industry. This veterinary hematology analyzer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary hematology analyzer market consists of sales of manual, semi-automated, and fully automated hematology analyzers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.